Skip to main content
ALIVUS LIFE SCIENCES LIMITED logo

ALIVUS LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · ALIVUS ISIN · INE03Q201024 LEI · 335800RYVA1DKP696G32 BSE.NS Manufacturing
Filings indexed 352 across all filing types
Latest filing 2024-08-28 Regulatory Filings
Country IN India
Listing BSE.NS ALIVUS

About ALIVUS LIFE SCIENCES LIMITED

https://www.alivus.com

Alivus Life Sciences Limited is a pharmaceutical organization dedicated to the formulation, production, and commercialization of a broad spectrum of healthcare solutions. The company operates across multiple therapeutic categories, including gastroenterology, anti-infectives, pain management, and nutritional supplements. Its product range includes diverse delivery formats such as tablets, capsules, syrups, and injectable medications. Alivus Life Sciences focuses on maintaining rigorous quality control protocols and manufacturing excellence to deliver reliable therapeutic outcomes. The company utilizes a robust distribution infrastructure to supply its pharmaceutical products to healthcare providers and patients, prioritizing the accessibility of essential medicines and the continuous expansion of its therapeutic portfolio.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges (BSE and NSE) regarding the schedule of upcoming meetings with investors and analysts. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is about informing the exchanges of investor/analyst meetings, not the content of the meetings or any financial results. The document length is only 2173 characters, which is quite short and does not contain any financial data, report, or detailed presentation. It is an announcement of an event (investor/analyst meeting) rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2130 characters) addressed to stock exchanges regarding upcoming investor/analyst meetings. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an intimation about scheduled meetings, not a financial report or detailed presentation. It does not contain financial data, management discussion, or audit information. The document is essentially an announcement of investor/analyst meetings, which fits best under Regulatory Filings (RNS) as a general regulatory announcement. It is not a report publication announcement since it does not mention any report release or attachment. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-08-19 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) providing an update on the revocation of a closure notice for the company's Ankleshwar facility by the Gujarat Pollution Control Board (GPCB). It references a regulatory compliance requirement under SEBI LODR, 2015, specifically Regulation 30 related to disclosure of material events. The content is an announcement of a regulatory event affecting the company, including environmental compliance and operational status, but does not contain financial statements, detailed financial analysis, or comprehensive report data. The document length is 3261 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. It is not a financial report, earnings release, or management discussion, but a regulatory update on a legal/environmental matter. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-08-14 English
Monitoring Agency Report
Regulatory Filings
2024-08-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges (BSE and NSE) regarding an upcoming meeting with investors/analysts. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) – Regulations, 2015, which pertains to disclosure of material events. The content is an intimation about an investor/analyst meeting scheduled for a future date. The document length is only 2106 characters, which is quite short and does not contain any financial data, report, or detailed presentation. It is not a report itself but an announcement of a meeting. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges (BSE and NSE) regarding an upcoming investor/analyst meeting scheduled for August 12, 2024. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The document does not contain any financial data, report content, or detailed presentation materials. It is an announcement of an event (investor/analyst meeting) rather than the meeting materials or transcript itself. The document length is only 2116 characters, which is short and typical for a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.